Sumimasa Nagai1, Reiko Yanagihara2, Yasuhiro Kishioka3. 1. Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan; Division of Genetic Therapeutics, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan. Electronic address: sunagai-tky@umin.ac.jp. 2. Office of Standards and Guidelines Development, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. 3. Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Authors: Thomas Dörner; Vibeke Strand; Paul Cornes; João Gonçalves; László Gulácsi; Jonathan Kay; Tore K Kvien; Josef Smolen; Yoshiya Tanaka; Gerd R Burmester Journal: Ann Rheum Dis Date: 2016-03-08 Impact factor: 19.103
Authors: Hans-Christian Kolberg; Marco Colleoni; Patricia Santi; Georgia Savva Demetriou; Miguel Angel Segui-Palmer; Yasuhiro Fujiwara; Sara A Hurvitz; Vladimir Hanes Journal: Target Oncol Date: 2019-12 Impact factor: 4.493